These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26119671)

  • 1. Age is Associated with Upgrading at Confirmatory Biopsy among Men with Prostate Cancer Treated with Active Surveillance.
    Anderson CB; Sternberg IA; Karen-Paz G; Kim PH; Sjoberg D; Vargas HA; Touijer K; Eastham JA; Ehdaie B
    J Urol; 2015 Dec; 194(6):1607-11. PubMed ID: 26119671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
    Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
    BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer.
    Vargas HA; Akin O; Afaq A; Goldman D; Zheng J; Moskowitz CS; Shukla-Dave A; Eastham J; Scardino P; Hricak H
    J Urol; 2012 Nov; 188(5):1732-8. PubMed ID: 23017866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Resonance Imaging-Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer.
    Jayadevan R; Felker ER; Kwan L; Barsa DE; Zhang H; Sisk AE; Delfin M; Marks LS
    JAMA Netw Open; 2019 Sep; 2(9):e1911019. PubMed ID: 31509206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis.
    Schoots IG; Nieboer D; Giganti F; Moore CM; Bangma CH; Roobol MJ
    BJU Int; 2018 Dec; 122(6):946-958. PubMed ID: 29679430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer.
    Nassiri N; Margolis DJ; Natarajan S; Sharma DS; Huang J; Dorey FJ; Marks LS
    J Urol; 2017 Mar; 197(3 Pt 1):632-639. PubMed ID: 27639713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance.
    Tran GN; Leapman MS; Nguyen HG; Cowan JE; Shinohara K; Westphalen AC; Carroll PR
    Eur Urol; 2017 Aug; 72(2):275-281. PubMed ID: 27595378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of early transperineal template-guided prostate biopsy for risk stratification in men undergoing active surveillance for prostate cancer.
    Voss J; Pal R; Ahmed S; Hannah M; Jaulim A; Walton T
    BJU Int; 2018 Jun; 121(6):863-870. PubMed ID: 29239082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing Age and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men with Gleason Score 6 Prostate Cancer.
    Leeman JE; Chen MH; Huland H; Graefen M; D'Amico AV; Tilki D
    Clin Genitourin Cancer; 2019 Dec; 17(6):e1116-e1121. PubMed ID: 31601512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer.
    Yang DD; Mahal BA; Muralidhar V; Nezolosky MD; Vastola ME; Labe SA; Boldbaatar N; King MT; Martin NE; Orio PF; Beard CJ; Hoffman KE; Trinh QD; Spratt DE; Feng FY; Nguyen PL
    Eur Urol Focus; 2019 Jan; 5(1):69-76. PubMed ID: 28753811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate Cancer.
    Dinh KT; Mahal BA; Ziehr DR; Muralidhar V; Chen YW; Viswanathan VB; Nezolosky MD; Beard CJ; Choueiri TK; Martin NE; Orio PF; Sweeney CJ; Trinh QD; Nguyen PL
    J Urol; 2015 Aug; 194(2):343-9. PubMed ID: 25681290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gleason Upgrading with Time in a Large Prostate Cancer Active Surveillance Cohort.
    Jain S; Loblaw A; Vesprini D; Zhang L; Kattan MW; Mamedov A; Jethava V; Sethukavalan P; Yu C; Klotz L
    J Urol; 2015 Jul; 194(1):79-84. PubMed ID: 25660208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active Surveillance.
    Kornberg Z; Cowan JE; Westphalen AC; Cooperberg MR; Chan JM; Zhao S; Shinohara K; Carroll PR
    J Urol; 2019 Feb; 201(2):300-307. PubMed ID: 30179620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.
    Vellekoop A; Loeb S; Folkvaljon Y; Stattin P
    J Urol; 2014 Feb; 191(2):350-7. PubMed ID: 24071481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes.
    Hussein AA; Welty CJ; Ameli N; Cowan JE; Leapman M; Porten SP; Shinohara K; Carroll PR
    J Urol; 2015 Jul; 194(1):85-90. PubMed ID: 25623742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Resonance Imaging-Guided Biopsy in Active Surveillance of Prostate Cancer.
    Kinnaird A; Yerram NK; O'Connor L; Brisbane W; Sharma V; Chuang R; Jayadevan R; Ahdoot M; Daneshvar M; Priester A; Delfin M; Tran E; Barsa DE; Sisk A; Reiter RE; Felker E; Raman S; Kwan L; Choyke PL; Merino MJ; Wood BJ; Turkbey B; Pinto PA; Marks LS
    J Urol; 2022 Apr; 207(4):823-831. PubMed ID: 34854746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance.
    Berglund RK; Masterson TA; Vora KC; Eggener SE; Eastham JA; Guillonneau BD
    J Urol; 2008 Nov; 180(5):1964-7; discussion 1967-8. PubMed ID: 18801515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbid Disease Burden is Independently Associated with Higher Risk Disease at Prostatectomy in Patients Eligible for Active Surveillance.
    Maurice MJ; Zhu H; Kiechle JE; Kim SP; Abouassaly R
    J Urol; 2016 Apr; 195(4 Pt 1):919-24. PubMed ID: 26519653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Active Surveillance after Initial Surveillance Prostate Biopsy.
    Kovac E; Lieser G; Elshafei A; Jones JS; Klein EA; Stephenson AJ
    J Urol; 2017 Jan; 197(1):84-89. PubMed ID: 27449260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy.
    Muthigi A; George AK; Sidana A; Kongnyuy M; Simon R; Moreno V; Merino MJ; Choyke PL; Turkbey B; Wood BJ; Pinto PA
    J Urol; 2017 Feb; 197(2):327-334. PubMed ID: 27582434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.